Request for Information (RFI): OII-Extended Reality/Reality Simulation Training & Development Capability

This Request for Information (RFI) is being issued by the Food and Drug Administration (FDA) in accordance with Federal Acquisition Regulations (FAR) Part 10, Market Research. It is for information, planning and market research purposes only and shall not be construed as either a solicitation or obligation on the part of the FDA or its Centers.

The purpose of this RFI is to broaden FDA’s understanding of current market capability on Artificial Intelligence-powered Extended Reality (XR) reality simulation tools such as Augmented Reality (AR) or Virtual Application (VR) training platforms to provide the next generation immersive learning, experiential learning, and microlearning opportunities for FDA regulatory inspection/investigation workforce.

Responses are to be submitted to Vivianna Diaz, Vivianna.diaz@fda.hhs.gov , Contract Specialist. Email is preferred. Please include the RFI number in the response. Do not send information that requires a non-disclosure agreement or sensitive business information. Telephone inquiries will not be accepted or acknowledged, and no feedback or evaluations will be provided to companies regarding their submissions. Interested companies must submit a Capability Statement limited to 10 pages that provides responses to the following requested information. Capability statements will not be returned and will not be accepted after the due date.